The effect of supplemental chromium as chromium-methionine (Cr-Met) on production and metabolic parameters was investigated in 48 cows from 28 d before expected calving date through 28 d of lactation. Average body weight (BW) was 730 +/- 61 kg before treatment. Treatments were supplementation of 0, 0.03, 0.06, and 0.12 mg of Cr as Cr-Met/kg of BW(0.75). Dry matter intake increased linearly and quadratically during the prepartum and postpartum periods, respectively, and body condition score loss decreased linearly during the postpartum period with increasing Cr-Met. Increasing Cr-Met supplementation caused quadratic increases in milk, fat, and lactose yields. Treatments did not affect concentrations of blood metabolites and liver triglyceride. Serum insulin concentration and molar ratio of insulin to glucose for cows receiving Cr-Met were lower than for cows not receiving Cr-Met, but they increased quadratically with increasing Cr-Met. Glucose tolerance tests (GTT) were conducted on d 10 prepartum and d 28 postpartum. Chromium-methionine supplementation attenuated insulin sensitivity prepartum and enhanced glucose tolerance postpartum, but not prepartum. Basal insulin concentrations for cows receiving Cr-Met were higher than for cows not receiving Cr-Met during the prepartum GTT. During the postpartum GTT, peak glucose concentration and clearance rate decreased and half-life (t(1/2)) and time to reach basal concentration (T) were prolonged quadratically by increasing Cr-Met. Additionally, peak insulin concentration, area under the curve, and molar ratio of insulin to glucose were higher for cows not receiving Cr-Met than for cows receiving Cr-Met and t(1/2) and T were shortened quadratically by increasing Cr-Met.
Six multiparous Holstein cows (average 31 days in milk; 36.3 kg/d of milk) fitted with ruminal cannulas were used in a 6 x 6 Latin square with 21-d periods to investigate the effects of diets that varied in forage source and amount of supplemental tallow. Isonitrogenous diets in a 2 x 3 factorial arrangement were based on either high corn silage (40:10 corn silage to alfalfa silage, % of dry matter) or high alfalfa silage (10:40 corn silage to alfalfa silage, % of dry matter) and contained 0, 2, or 4% tallow. Intakes of dry matter and total fatty acids were lower when cows were fed the high corn silage diet. Tallow supplementation linearly decreased dry matter intake. Milk yield was unaffected by diet; yields of milk fat and 3.5% fat-corrected milk were higher for the high alfalfa silage diet but were unaffected by tallow. Milk fat percentage was higher for the high alfalfa silage and tended to decrease when tallow was added to the high corn silage diet. Contents of trans-C18:1 isomers in milk fat were increased by high corn silage and tallow, and tended to be increased more when tallow was fed in the high corn silage diet. Ruminal pH and acetate:propionate were lower when high corn silage was fed. Ruminal acetate:propionate decreased linearly as tallow increased; the molar proportion of acetate was decreased more when tallow was added to the high corn silage diet. Ruminal liquid dilution rates were higher for the alfalfa silage diet; ruminal volume and solid passage rates were similar among diets. Total tract apparent digestibilities of dry matter, organic matter, crude protein, starch, energy, and total fatty acids were unaffected by diet. Digestibilities of neutral detergent fiber, acid detergent fiber, hemicellulose, and cellulose were lower when high corn silage was fed. The high alfalfa silage diet increased intakes of metabolizable energy and N, and increased milk energy and productive N. Tallow decreased the amount of N absorbed but had few other effects on utilization of energy or N. Tallow linearly increased concentrations of nonesterified fatty acids and cholesterol in plasma; cholesterol was increased by high alfalfa silage. Overall, forage source had more pronounced effects on production and metabolism than did tallow supplementation. Few interactions between forage source and tallow supplementation were detected except that ruminal fermentation and milk fat content were affected more negatively when tallow was fed in the high corn silage diet.
Six cows were utilized in a 6 x 6 Latin square design with 21-d periods to determine effects of the postruminal profile of fatty acids on dry matter (DM) intake, milk yield and composition, nutrient digestibilities, and plasma metabolites. Treatments were abomasal infusions of 1) control [168 g/d of meat solubles (carrier for fatty acids) plus 10.6 g/d of Tween 80 (emulsifier)], 2) control plus 450 g/d of mostly saturated fatty acids, 3) control plus 450 g/d of palm oil fatty acids low in linoleic acid, 4) control plus 450 g/d of palm oil fatty acids, 5) control plus 450 g/d of soybean oil fatty acids, and 6) control plus 450 g/d of soybean oil fatty acids high in palmitic acid. Treatments 2, 3, 4, and 6 contained similar ratios of C16 to C18 fatty acids. Infusion of soybean oil fatty acids or soybean oil fatty acids high in palmitic acid decreased intakes of DM, organic matter, crude protein, acid detergent fiber, neutral detergent fiber, gross energy, and total fatty acids and tended to decrease yields of milk and fat-corrected milk compared with the infusion of mostly saturated fatty acids. Infusion of palm oil fatty acids low in linoleic acid or palm oil fatty acids decreased milk fat percentage compared with other treatments. Ruminal characteristics and apparent digestibilities of DM, organic matter, crude protein, acid detergent fiber, neutral detergent fiber, energy, total fatty acids, and total C18 fatty acids were not different. Infusion of fatty acids increased concentrations of cholesterol in plasma. The amount of unsaturated fatty acids passing into the small intestine may influence responses of dairy cows to supplemental fat.
Two experiments were conducted to test the following two hypotheses: 1) fatty liver could hamper hepatic conversion of ammonia to urea and increase circulating ammonia or Gln% [Gln% = Gln x 100/(Gln + Glu)] in cows around parturition; 2) decreased ureagenesis might cause alkalosis and in turn reduce blood Ca. In the first experiment, 14 Holstein cows were monitored from 27 d prepartum to 35 d postpartum. There was a rise in circulating ammonia and Gln% at calving, suggesting an increase in ammonia passing to and through the liver. Stepwise regression analysis revealed the following relationship for plasma samples at 22 h and liver triglyceride at 2 d postpartum: ammonia (microM) = 32.1+/-0.89 triglyceride (% DM), Gln% = 71.2 + 0.23 triglyceride (% DM) + 1.31 urea (mM). The positive correlation between liver triglyceride and plasma ammonia and Gln% suggests that hepatic triglyceride accumulation might inhibit ureagenesis, thereby increasing ammonia concentration at the perivenous hepatocytes where Gln synthesis occurs and increasing ammonia concentration in blood leaving the liver. In the second experiment, 28 rats were used to determine whether hepatic triglyceride accumulation, induced by choline deficiency, affects urinary ammonia N and blood pH homeostasis. There was a trend for a positive correlation between urinary ammonia N and liver triglyceride. No correlation between liver triglyceride and blood pH, bicarbonate, pCO2 or plasma Ca was found. In conclusion, hepatic triglyceride accumulation may inhibit ureagenesis and result in increased circulating ammonia, Gln% and urinary ammonia N in vivo. Hepatic triglyceride accumulation did not affect blood pH homeostasis.
We conducted three experiments to determine the effects of nutritional and hormonal status on microsomal triglyceride transfer protein (MTP) activity and mass. In experiment 1, 18 nonlactating Holstein cows, 75 d before expected calving date, in their second gestation or greater were monitored from d 75 to 55 prepartum. Cows were fed a control diet from d 75 to 62 prepartum for covariable measurements. From d 61 to 55 prepartum, six cows continued to receive the control diet, six cows were restricted to 2.3 kg of grass hay/d, and six cows were fed the control diet plus 1.8 kg of concentrate/d and 500 ml of propylene glycol given 2 times/d as an oral drench. Plasma glucose and serum insulin concentrations were highest in cows that received propylene glycol and lowest in feed restricted cows. Plasma nonesterified fatty acids (NEFA) and liver triglyceride (TG) concentrations were highest in feed restricted cows and not different between cows that received the control diet and cows that received propylene glycol. Hepatic MTP activity and mass were not affected by treatment in experiment 1. In experiment 2, bovine hepatocytes isolated from the caudate process of five preruminating Holstein bull calves were incubated with either 0, 0.5, 1.0, or 2.0 mM NEFA for 48 h. Intracellular TG increased linearly as NEFA concentration in the media increased. Concentration of NEFA in the incubation media had no effect on MTP activity or mass. There was a quadratic effect of concentration of NEFA in the incubation media on MTP mRNA. In experiment 3, bovine hepatocytes isolated from the caudate process of five preruminating Holstein bull calves were incubated with 2 mM [1-14C]oleate for 24 h to accumulate TG, followed by a 36-h period of TG depletion, during which hepatocytes were incubated with no hormone, 10 nM insulin, or 10 nM glucagon. There was no effect of insulin or glucagon on intracellular TG, MTP activity or mass. Cells incubated with no hormone had higher levels of MTP mRNA compared to cells incubated with insulin or glucagon during the depletion period. Results suggest that hepatic MTP mRNA may be affected by TG accumulation, insulin, and glucagon in vitro. However, hepatic MTP activity and mass are not affected by nutritional status of nonlactating dairy cows, TG accumulation in vitro, or insulin and glucagon in vitro.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.